#United States #New York #Securities Fraud #Pomerantz LLP #Viatris

Pomerantz Law Firm Investigates Viatris Inc.

On March 17, 2025, the Pomerantz Law Firm, a well-known leader in corporate litigation, announced its investigation regarding claims from investors of Viatris Inc. (NASDAQ: VTRS). This inquiry is significant as it centers on possible securities fraud and other questionable business practices allegedly implemented by the company and its officials.

Context of the Investigation

The investigation follows a press release issued by Viatris on February 27, 2025, in which the company disclosed its financial results for the fourth quarter and the full year of 2024. The results fell short of market expectations across various key performance metrics, causing investors to express concern. Furthermore, the company projected lower-than-anticipated guidance for its full-year 2025 performance, raising further red flags about its operational status and financial management.

Adding to investor anxiety, Viatris also communicated challenges related to a manufacturing facility located in India. The facility is undergoing remediation efforts following a warning letter and import alert issued by the U.S. Food and Drug Administration (FDA). The company reported that it was making progress on this front, stating that it was more than halfway through the necessary remediation and expected to request a reinspection by the FDA upon completion.

Recent Stock Performance

In light of these disclosures, Viatris's stock price faced a significant decline, dropping $1.71 per share, which translates to a 15.21% decrease, closing at $9.53 per share on the same day the news was released. This downward trend is alarming for investors who rely on transparent and accurate information when making decisions regarding their investments.

Role of Pomerantz LLP

The Pomerantz Law Firm has built a reputation as one of the foremost law firms in the realm of corporate, securities, and antitrust class actions. Established by the late Abraham L. Pomerantz, who is often referred to as the dean of class action bar, the firm has a long-standing history of advocating for victims of securities fraud and corporate misconduct. They have successfully recovered substantial settlements and damages for affected investors over the past 85 years.

For investors who believe they have incurred losses due to the potential fraudulent actions of Viatris and are interested in joining this class action investigation, they are encouraged to contact Danielle Peyton. She can be reached at 646-581-9980, extension 7980, or via email at [email protected].

The ongoing inquiry highlights the importance of corporate accountability and the need for firms like Pomerantz to step in when investors' rights may have been compromised. As this situation develops, investors will be keenly observing Viatris's next steps regarding both its financial management and regulatory compliance.

This potential class action serves as a reminder of the critical nature of transparency in the financial markets, and the necessity for companies to uphold integrity in their communication with investors.

For continued updates on this investigation and other news about Viatris, stakeholders should stay connected with news outlets and financial advisories.